Liver

 

Reducing Cardiovascular Risk
in the Diabetic Patient

Can We Develop a Viable PPAR
Agonist for Diabetic Patients?
and Challenges in Developing New
Therapies for Risk Reduction in Diabetes

This activity has expired.
You will be redirected to our Cardiology page shortly to find related content in this specialty.